Non-canonical CRISPR/Cas12a-based technology: A novel horizon for biosensing in nucleic acid detection

Jan 17, 2024Talanta

New CRISPR/Cas12a method for detecting genetic material in biosensors

AI simplified

Abstract

Non-canonical CRISPR/Cas12a-based biosensors may improve nucleic acid detection capabilities.

  • Canonical CRISPR/Cas12a biosensors are known for their high specificity and simple operation but struggle with sensitivity and efficiency.
  • Non-canonical CRISPR/Cas12a biosensors could address limitations related to target scope, multiplexing, and signal detection.
  • This review summarizes the applications, principles, and characteristics of non-canonical CRISPR/Cas12a-based biosensors.
  • Performance metrics and future prospects of these advanced biosensors are discussed.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free